Compare GNL & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNL | LMAT |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2011 | 2006 |
| Metric | GNL | LMAT |
|---|---|---|
| Price | $9.02 | $82.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $9.67 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 2.6M | 363.5K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 7.98% | 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | ★ $495,286,000.00 | $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | $1.95 | $8.88 |
| P/E Ratio | ★ N/A | $57.84 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $7.45 | $78.65 |
| 52 Week High | $10.04 | $118.01 |
| Indicator | GNL | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 51.00 | 34.31 |
| Support Level | $8.84 | $81.68 |
| Resistance Level | $9.66 | $89.00 |
| Average True Range (ATR) | 0.20 | 3.78 |
| MACD | 0.04 | -1.92 |
| Stochastic Oscillator | 65.00 | 12.75 |
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operation, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution, Retail, and Office. The company derives maximum revenue from the Industrial and Distribution segment. The company geographically operates in the United States, the United Kingdom, Canada, and Europe.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.